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Abstract
Transmissible spongiform encephalopathies (TSE) are fatal neurodegenerative disorders caused by prions. Animal TSE
include scrapie in sheep and goats, and chronic wasting disease (CWD) in cervids. Effective management of scrapie in many
parts of the world, and of CWD in North American deer population is complicated by the persistence of prions in the
environment. After shedding from diseased animals, prions persist in soil, withstanding biotic and abiotic degradation. As
soil is a complex, multi-component system of both mineral and organic components, it is important to understand which
soil compounds may interact with prions and thus contribute to disease transmission. Several studies have investigated the
role of different soil minerals in prion adsorption and infectivity; we focused our attention on the interaction of soil organic
components, the humic substances (HS), with recombinant prion protein (recPrP) material. We evaluated the kinetics of
recPrP adsorption, providing a structural and biochemical characterization of chemical adducts using different experimental
approaches. Here we show that HS act as potent anti-prion agents in prion infected neuronal cells and in the amyloid
seeding assays: HS adsorb both recPrP and prions, thus sequestering them from the prion replication process. We
interpreted our findings as highly relevant from an environmental point of view, as the adsorption of prions in HS may affect
their availability and consequently hinder the environmental transmission of prion diseases in ruminants.
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Introduction
Prions are proteinaceous infectious agents causing a heteroge-
neous group of invariably fatal neurodegenerative disorders
denoted as transmissible spongiform encephalopathies (TSE) or
prion diseases. Creutzfeldt-Jakob disease (CJD) is the most
common form of TSE in humans whereas animal TSE include
scrapie in sheep and goat, chronic wasting disease (CWD) in
cervids and bovine spongiform encephalopathy (BSE) in cattle [1].
The central event leading to prion formation is the conformational
conversion of the ubiquitously expressed cellular form of the prion
protein (PrPC) to a misfolded isoform denoted as prion or PrPSc
[2]. Unlike PrPC, PrPSc is amyloidogenic, unusually resistant to
proteolytic enzymes and enriched in b-sheet secondary structure
motifs [3].
Prion diseases uniquely manifest as sporadic, inherited or
iatrogenic, i.e. prions are acquired through infectious routes. In
ruminants, scrapie and CWD can be transmitted via environmen-
tal routes, while BSE is transmitted almost exclusively through
foodborne carriages [4]. In natural environments, prions are most
likely acquired via oral intake [5–7]; amplification of PrPSc follows
in the lymphoid tissues associated with the gut of the host [8]. In
BSE, PrPSc accumulation has been largely found within the CNS
[9] whereas scrapie and CWD have exhibited a widespread prion
distribution in different tissues [10,11]. The PrPSc tropism
observed in sheep and cervids accounts for the facile TSE
transmission among these animals, which may disseminate prions
via multiple excretion routes [12]. The occurrence of endemic
scrapie and CWD reported in affected areas points to the presence
of environmental reservoirs. It is accepted that soil may harbor
prion infectivity –PrPSc is resistant to biotic and abiotic
degradation and can persist in soil for years [13–15]. Soil-bound
prions retain infectivity, as experimentally validated in intracere-
bral [16–19], oral and intranasal infection studies [20,21]. PrPSc
bound to soil particle surfaces is mediated by electrostatics and
hydrophobic interactions [16,22,23]. Prions may interact with
other soil constituents such as organic matter (OM). In particular,
PrPSc can interact with humic substances (HS) –currently defined
as supramolecular, meta-stable structures of self-assembled mole-
cules held together by multiple weak interactions [24–26]. Humic
and fulvic acids (HA and FA, respectively) constitute HS.
Differently from HA, FA have lower molecular weight, higher
functional group density and higher acidity [27]. HS can interact
with xenobiotics and proteins and polymerize, forming large
molecular ensembles. The interaction between HS and proteins
under different experimental conditions has been described as
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encapsulation of the polypeptides into the inner HS structure [28–
31]. Previous interaction studies between recombinant prion
proteins (recPrP) and HS have shown that HS impact recPrP
adsorption, forming insoluble complexes with the protein [32–35].
A comparison of epidemiological CWD data with soil clay content
in a delimited geographic region (Northern Colorado, Colorado
State, USA) has shown that the odds of prion infection in deer are
increased in soil areas with high clay content but poor in OM [36].
The interaction of prions with soil OM may be highly
environmentally relevant for soils rich in HS, but the mechanism
of HS-PrPSc interaction and the influence of HS on prion
infectivity are not well understood.
To provide more clues on the role of HS in limiting prion
infectivity, we investigated the adsorption of murine full-length
recPrP (MoPrP) to natural HS. We characterized these supramo-
lecular complexes by circular dichroism (CD), optical and atomic
force microscopy (AFM). We analyzed how HS adsorbing MoPrP
hinder proteolytic degradation, and we evaluated whether HS
limit prion conversion by using both a kinetic assay for PrPSc
conversion [37] and a neuronal cell culture model (ScGT1)
chronically infected with the Rocky Mountain Laboratory (RML)
prion strain [38]. Our findings on HS interacting with MoPrP add
evidence for their role as anti-prion complexants. Our study may
contribute to better understand the large complexity of environ-
mental factors that impact prion persistence and infectivity in soil.
Materials and Methods
Extraction and Purification of Humic Substances
A composite sample of a meadow soil from northeastern Italy
was collected at 5–30 cm depth. No specific permissions were
required for these sampling activities in this location. The field
studies did not involve endangered or protected species. The GPS
coordinates of the private land where the soil was collected are
45.9344u in latitude and 13.6136u in longitude. Contact the
corresponding authors to request authorization for further use of
this material. The soil was a sandy loam Mollic Hapludalf (USDA)
composed of 67% sand, 21% silt, 12% clay, 2.2% organic C,
0.21% total N and 10.5 organic C/total N ratio at pH 6.8. Soil
HS were extracted according to the International Humic
Substances Society (IHSS) guidelines. HA and FA were purified
according to [39]. HS quantification was based on the organic
carbon content and expressed as mg/mL of HS. The stock
solutions of HA and FA were autoclaved and diluted to 0.5 mg/
mL in acetate buffer (20 mM NaOAc, 0.005% NaN3, pH 5.5).
The pH was monitored prior to use.
MoPrP Expression and Purification
The plasmid pET-11a (Novagen) encoding for the full-length
MoPrP(23–230) was kindly provided by Prof. J.R. Requena
(University of Santiago de Compostela, Santiago de Compostela,
Spain). An overnight culture of E. coli Rosetta 2 (DE3) (Novagen)
freshly transformed with the plasmid was added at 37uC to 2 L of
Zym-5052 medium [40]. Cells were grown in a 2 L fermenter
system (Sartorius), harvested after 24 hours and lysed by
homogenizer (Panda plus, GEA Niro Soavi). Inclusion bodies
were washed and solubilized according to [41]. MoPrP was
purified using its octapeptide repeat sequence as natural affinity
tag for nickel. MoPrP was loaded onto a 5-mL HisTrap column
(GE Healthcare) equilibrated in binding buffer (2 M GndHCl,
500 mM NaCl, 20 mM Tris, pH 8) and eluted with 500 mM
imidazole. Subsequently, the protein was purified by reverse phase
(Jupiter C4, Phenomenex) and separated using a gradient of 0–
95% acetonitrile and 0.1% trifluoroacetic acid. The purified
protein was lyophilized and refolded in acetate buffer (25 mM
NaOAc, 0.005% NaN3, pH 5.5) according to [41].
Circular Dichroism and SDS-PAGE Gel Experiments
Samples for SDS-PAGE gel experiments consisted of 125 mg/
mL MoPrP incubated for 12 hours at 22uC in the presence of
increasing amounts of HS (1, 5, 7.5, 10 and 20 mg/mL of HA and
FA) in a volume of 50 mL in buffer acetate (25 mM NaOAc,
0.005% NaN3, pH 5.5). After incubation, samples were centri-
fuged at 16,000 g for 45 min to separate the soluble protein from
the precipitated fractions. Supernatants and pellets were boiled for
10 min in 4X loading buffer (5 M Urea, 10% SDS, 0.25 M Tris
HCl, 0.4 M DTT, 30% Glycerol, 0.04% bromophenol blue,
pH 6.8), loaded onto 12% SDS-PAGE gel. Circular dichroism
(CD) spectra were recorded over the 195 to 260 nm range using a
CD spectrometer (Jasco Inc.) at 22uC. Samples were prepared
with 125 mg/mL of MoPrP incubated either in the presence or
absence of HS (1, 5, 7.5, 10 and 20 mg/mL of HA and FA) for 6
and 240 hours at 22uC in buffer acetate. After incubation, samples
were centrifuged at 16,000 g for 45 min to separate the soluble
protein from the precipitate. CD spectra on supernatants were
accumulated three times and acquired in triplicate using a 1-mm
path-length cell. To estimate the concentration of MoPrP in
solution after HS addition, we acquired CD spectra of MoPrP
standards (125, 100, 75 and 50 mg/mL) and derived the equations
resulting from the linear fitting of the mdeg value at 208 nm versus
the MoPrP standards. The CD spectra of the samples treated with
HA or FA were then normalized in molar ellipticity (h). Due to the
CD intrinsic sensitivity limit, only spectra with a minimum of
about 24 mdeg at 208 nm were normalized. CD data were
processed by Spectra Manager 1.52.01 and Origin 8.6 software.
AFM and Optical Microscopy of MoPrP-HS Complexes
Two MoPrP concentrations (25 and 60 mg/mL) were incubated
with 5 and 20 mg/mL of HA or FA in 50 mL volume at 22uC for 6
hours. All the samples were prepared by drop casting on a surface
of freshly cleaved muscovite mica and left to adhere till total
solvent evaporation. All AFM measurements were performed on a
standard MFP-3D stand alone Asylum Research AFM (Oxford
Instruments, UK) in dynamic mode using commercially available
silicon probes (NSG30 cantilever characterized by a spring
constant of about 40 nN/nm, resonance frequency of about
340 kHz and tip radius less than 6 nm). Images were acquired in
air at a resolution of 5126512 pixels at 1 Hz scan speed. Optical
microscopy characterization was performed on a Nikon Eclipse
Ti-U inverted microscope. Phase images were recorded with a
Nikon Digital Sight DS-2 Mv camera at 160061200 pixels
resolution on a 206 objective.
Protease-K Digestion on HS-adsorbed MoPrP
Samples for the digestions consisted of 125 mg/mL of MoPrP
incubated in the presence of 20 mg/mL HS at 22uC for 6 hours in
a final volume of 50 mL, and then centrifuged at 16,000 g for
45 min to separate the precipitated protein. Pellets were
resuspended twice in 50 mL of acetate buffer. Samples were
digested with increasing concentrations of Protease-K (PK)
(Roche) (1, 5, 10, 25, 50 and 100 mg/mL) for 1 hour at 37uC.
The reactions were stopped adding 5 mM of phenylmethylsulfonyl
fluoride (PMSF), boiled for 15 min in 4X loading buffer, loaded
onto a 12% SPS-PAGE gel and blotted on Immobilion PVDF
(Millipore) membrane. Membrane was probed with anti-PrP
monoclonal antibody W226 and developed by enhanced chemi-
luminescence (GE Healthcare). Band intensity was acquired using
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PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e100016
the UVI Soft software (UVITEC, Cambridge). As non-PK
control, we loaded 0.1 mg of MoPrP to avoid signal saturation.
Monitoring the Kinetics of in vitro Fibril Formation by
Amyloid Seeding Assay
To monitor the formation of ThT-positive fibrils, we used
50 mg/mL of a-helix folded MoPrP in acetate buffer. To induce
protein polymerization we added to the reaction a preformed
PrPSc seed chemically purified from ScGT1 cells [42]. First, the
amyloid seeding assay (ASA) was performed incubating the PrPSc
seed with MoPrP for 6 hours, and then HS were added to the
reaction. In a second ASA, the seed was incubated with 1 mg/mL
HS for 6 hours and then we added MoPrP. MoPrP and MoPrP
incubated with 1 mg/mL HS were used as negative controls. ASA
was performed in a final volume of 100 mL using a 96-well plate
(PerkinElmer). Experiments were performed at least in quadru-
plicate and the plate was incubated at 37uC with continuous
shaking on a plate reader (Spectramax M5, Molecular Device).
The polymerization process was monitored for 110 hours by
reading the ThT-fluorescence intensity at 444 nm excitation and
485 nm emission. The time of fibrillization (lag phase) was
estimated according to [43], data were analyzed using Origin 8.6
software.
Cell Culture Experiments
ScGT1 cells were cultivated in 10-cm-diameter plates contain-
ing 10 mL of DMEM supplemented with 10% FBS and 1%
penicillin-streptomycin, and grown to 95% confluence for 1 week
before splitting at 1:10 for further cultivation. Cells were treated
with increasing concentrations of HA or FA (1, 5, 7.5 and 10 mg/
mL of HS) and incubated for 6 days at 37uC, 5% CO2. PrP
Sc
accumulation was detected by immunoblotting the PK-digested
cell lysates. Five hundred mg of ScGT1 cell lysates total protein was
digested by 50 mg/mL of PK (Roche) for 1 hour at 37uC. The
reaction was stopped with 5 mM PMSF and the PK-digested cell
lysates were ultracentrifuged at 100,000 g for 1 hour at 4uC
(Beckman Coulter, Inc.). The pellets were resuspended in 4X
loading buffer, boiled for 10 min and immuno-blotted as described
above. Fifty mg of ScGT1 was loaded as non-PK control. The half-
maximal effective concentration (EC50) and the PrP
Sc quantifica-
tion upon HA and FA treatments (at a concentration of 5, 7.5, 10
and 20 mg/mL of HS) were determined using the ELISA assay
according to [42]. To evaluate cell viability after HS treatments,
we performed the calcein-AM assay (R&D Systems Europe, Ltd.).
ScGT1 cells were maintained in DMEM and supplemented with
10% FBS. After one day of incubation, cellular density was
determined by cell counting using a haemacytometer. Cell density
was adjusted to 2.56105 cells/mL with DMEM for ScGT1 cells.
HA and FA were added to wells at different concentrations (1, 5,
7.5, 10 and 20 mg/mL of HS). Media were aspirated after 6 days
of incubation and cells were washed twice with 200 mL of PBS.
One hundred mL of 2.5 mM calcein-AM was added and the plates
were incubated at 37uC for 30 min. Fluorescence emission
intensity was quantified using a fluorescence plate reader
(Spectramax M5, Molecular Device) with a 492/525 nm excita-
tion/emission ratio.
Results
Insolubility, Folding and Stability of HS-bound Prion
Protein
To test the interaction between HS and MoPrP, the protein was
incubated with increasing concentrations of HA or FA. After 12
hours of incubation with HS, the protein was completely
precipitated and present in the insoluble fractions upon addition
of up to 20 mg/mL of HS (Figure 1A). Next, we performed CD
spectroscopy experiments to evaluate the effect of HS adsorption
on MoPrP solubility and folding over time. Differently from other
protein detection methods [44], CD spectroscopy detected no
interference in HS (Figure S1). Addition of HA or FA causes an
increase in millidegree (mdeg) values indicating the gradual
MoPrP sequestration from the solution after 6 hours of incubation
with HA or FA, and 240 hours of incubation with HA (Figure S1).
The correct concentration of soluble MoPrP after HS addition was
inferred by a calibration curve (Figure S2). Our results suggest that
FA are more effective in inducing MoPrP precipitation, as 97%
and 58% of MoPrP was soluble after 6 hours of incubation with
5 mg/mL HA and FA, respectively. After 240 hours of prolonged
incubation with HA, the solubility of MoPrP decreased –from
75% of soluble MoPrP incubated with 10 mg/mL HA for 6 hours
to 55% incubated for 240 hours. No information was available for
long-term FA-MoPrP interaction, because the protein fully
precipitates after 6 hours of incubation with 10 mg/mL FA
(Figure 1B). Normalized CD spectra revealed that the remaining
protein in solution appeared in its native folding, showing the
canonical a-helical folded profile of MoPrP with two minima at
208 and 222 nm (Figure 1C) [45].
To better understand how prions can persist in the environment
for several years withstanding biotic or abiotic degradation we
tested MoPrP embedded in HS for resistance to PK digestion. To
avoid any possible interference of residual HS in solution and PK
activity, precipitated MoPrP-HS fractions were resuspended twice
in acetate buffer before adding the PK. Unlike the protein alone,
HS-adsorbed MoPrP is highly resistant to proteolytic digestion
after adding up to 50 mg/mL of PK (Figure 2). At low PK
concentrations, FA appear more effective than HA in protecting
MoPrP from degradation.
Optical Microscopy and AFM Characterization of MoPrP-
HS Macrocomplexes
To further characterize the protein-HS insoluble adducts we
analyzed their morphology by optical microscopy and AFM. The
macroscopic architectures of FA and HA deposited on mica at
20 mg/mL appeared very different. FA displayed regular, long
branched chain-like structures forming a fibrous network fairly
distributed on the surface (Figure 3A). Similar regular assemblies
were observed in FA-MoPrP complexes, although smaller
aggregated particles co-localizing with FA branches were visible
(Figure 3B red arrow and Figure 3C). Compared to FA, the optical
microscopy analysis on HA revealed a heterogeneous morphology,
with large aggregate assemblies (Figure 3D). These morphological
differences may be attributed to the different physicochemical
nature of FA and HA [27]. The adsorption of MoPrP to HA seems
to affect the overall distribution of the adducts on the mica surface
(Figure 3E), resulting by AFM in a polydisperse distribution of
discrete globular clusters with height and length of 0.6 mm and
30 mm, respectively (Figure 3F).
Next, we investigated by AFM the surface regions that appeared
devoid of the large FA branched chains or HA aggregates
observed by optical microscopy. HA showed aggregated structures
connected by gel-like filaments (Figure 4A) while FA samples
revealed the presence of globular clusters, which appeared as gel-
like clumps (Figure 4E). These morphologies were presumably
induced by strong water-HS interaction due to HS surface
charges.
HA and FA were further examined in the presence of two
different MoPrP concentrations (25 and 60 mg/mL) in order to
evaluate possible HS morphological changes induced by the
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protein. After MoPrP adsorption into HA, the assemblies became
more compact and heterogeneous, forming supramolecular
clusters in a protein concentration-dependent manner
(Figure 4B–D). Interestingly, in the presence of MoPrP, FA
associates in a completely different way. At low protein
concentration (25 mg/mL) a sponge-like structure on the surface
was visible (Figure 3F) suggesting a MoPrP effect on FA assembly.
This morphology appeared to rearrange in the complex formed by
60 mg/mL of MoPrP and FA. The porous layer-like structures
were significantly narrowed and small ordered assemblies were
visible (Figure 4G). A detailed analysis revealed fibrillar structures
with different topology, arranged as a thin film with a distribution
between 3 and 6 nm in height (Figure 4H). FA fibrils were as long
as 1 mm and composed of straight ribbon-like fibrils and fibrils
with occasional branching. The globe-shaped layer in panel D is
about 1.860.2 nm high, while fibers in panel H have a height of
about 1.660.4 nm. MoPrP deposited as control at 60 mg/mL
showed a homogeneous layer about 1.460.2 nm high, as
determined from a scratch made in the layer (Figure S3A). Next
we evaluated the morphological changes of the adducts by
decreasing the HS concentration to 5 mg/mL, a condition that
does not induce a complete protein precipitation. The AFM scans
showed initial rearrangements of the assemblies formed upon
addition of HA or FA. The MoPrP-HA complex appeared as an
amorphous layer uniformly dispersed on the surface, with an
average height of 6 nm (Figure S3B). Conversely, the MoPrP-FA
complex formed spherical globular clusters with a distribution of
9 nm in height (Figure S3C), confirming the ability of the FA-
MoPrP complex to arrange in regular structures.
Figure 1. MoPrP adsorption into HS affects protein solubility. SDS-PAGE gel showing the precipitation of full-length MoPrP induced by
increasing amounts of HA and FA. After adding 20 and 10 mg/mL of HS (HA and FA, respectively) the total protein is mainly present in the insoluble
fractions (A). Decreased MoPrP solubility in the presence of 1 to 5 mg/mL of FA after 6 hours of incubation, and 1 to 10 mg/mL of HA after 6 and 240
hours of incubation (B). Normalized far-UV CD spectra of MoPrP after 6- and 240-hour incubation with 5 mg/mL of HS (C).
doi:10.1371/journal.pone.0100016.g001
Figure 2. MoPrP adsorbed into HS is protected from PK
digestion. Western-blot experiments on MoPrP (first panel), MoPrP-
HA and MoPrP-FA complexes (second and third panel, respectively)
incubated with different PK concentrations.
doi:10.1371/journal.pone.0100016.g002
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Effectiveness of HS in Inhibiting Prion Replication
To investigate the possible role of HS in reducing prion
infectivity, first we used the amyloid seeding assay (ASA). In
contrast to the original protocol employing denaturants and high
ionic strength to accelerate the fibrillization reaction [37], we used
MoPrP in native conditions in the presence of 1 mg/mL of HS.
This concentration has a minor impact on protein solubility
(Figure 1) and does not interfere with Thioflavin-T (ThT)
fluorescence, the dye commonly used in ASA to monitor the
formation of newly generated b-strand-enriched structures. When
the protein was pre-incubated with PrPSc and then exposed to HA
and FA, the lag-phases of fibrillization were prolonged up to
88.264.7 and 84.569.4 hours, respectively, while the control
started to polymerize after 59.467.4 hours. To exclude that the
observed lag-phase shifts were due to a partial MoPrP removal
from the reaction induced by HS encapsulation, we preincubated
the seed with HS before adding MoPrP. Interestingly, in these
conditions we did not detect any ThT-fluorescence sigmoidal
increases in the reactions seeded by PrPSc complexed by HS
(Figure 5A and 5B). We obtained similar results, showing no ThT-
fluorescence increase, in control experiments performed in the
presence of HS without PrPSc seed (Figure S4). To investigate
whether HS have a significant effect in reducing PrPSc content in
more physiological conditions, we added HS to ScGT1 cells
medium and evaluated PK-resistant PrPSc levels, a test currently
employed to assess whether a compound displays anti-prion
activity [38]. As shown in Figure 5C, the treatment with HA and
FA induced a clearance of pre-existing PrPSc from ScGT1 cells in
a dose-dependent manner (lower panel) without altering the total
PrPC expression (upper panel). The half maximal effective concen-
trations (EC50) were 7.860.4 and 12.360.7 mg/mL for HA and
FA, respectively, as determined by ELISA [42]. None of the
compounds tested was cytotoxic after HS exposure (Figure S5).
These results provide first evidence that HS may play a role in
PrPSc adsorption, thus limiting prion transmission.
Discussion
Similarly to mineral components, organic matter significantly
affects soil physico-chemical properties, which may impact PrPSc
adsorption capacity and its stability in the environment.
As experimental model to describe the protein-HS interactions
here we used the full-length murine recPrP as surrogate for PrPSc.
Although MoPrP is not equivalent to PrPSc, as it has a different
structure and lacks glycosylation, it may provide important clues
about the protein stability inside HS and the mechanism of protein
encapsulation mediated by HA and FA. Our findings show that
HS are potent protein complexants that can form insoluble
assemblies. The stability of MoPrP adsorbed into HS was
confirmed by SDS-PAGE analysis showing no HS-mediated
abiotic degradation processes, as also previously reported in
recPrP-catechol interaction studies [35]. Because the chemical
formulas and molecular weights of HS are still controversial issues
[25], the direct comparison between HA and FA was precluded.
Therefore, we obtained semi-quantitative data about MoPrP
adsorption and folding upon HS interaction. CD experiments on
soluble MoPrP exposed to HS revealed that the protein secondary
structure remained unaltered. Limited information is available
about the folding of the insoluble HS-adsorbed MoPrP. However,
it is plausible that encapsulated MoPrP retains its native folding, as
Figure 3. Macroscopic characterization of humic substances. Phase contrast optical images of HS morphology when deposited on a mica
surface (20 mg/mL of FA and HA, respectively in A and D) were compared to MoPrP-HS complexes morphology deposited under the same conditions
(B shows complexes between 60 mg/mL of MoPrP and FA, E depicts those with HA). Red arrows in B point at ‘‘brush-like’’ structures possibly
ascribable to MoPrP clusters. Yellow squares highlight the FA and HA structures analyzed by AFM in panels C and D, representing three-dimensional
AFM reconstructions of FA-MoPrP fractal fibers and HA-MoPrP assemblies, respectively.
doi:10.1371/journal.pone.0100016.g003
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Figure 4. AFM characterization of HS and MoPrP-HS complexes. Surface morphology of HS alone (HA and FA in panels A and E, respectively)
and HS complexes with 25 mg/mL of MoPrP (in panels B and F corresponding to MoPrP-HA and MoPrP-FA complexes, respectively) and with 60 mg/
mL of MoPrP (in panels C and G with HA and FA, respectively). Panels D and H show high magnification images of the samples presented in panels C
and G.
doi:10.1371/journal.pone.0100016.g004
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observed in the fibrillization experiments where HS were not able
to promote MoPrP conversion in b-sheet enriched structures.
Moreover, previous experiments using Fourier infrared spectros-
copy and cross-polarization magic angle spinning (CP MAS) 13C-
solid state NMR spectroscopy have reported no detectable
conformational changes occurring on recPrP adsorbed in humic-
like substances, in spite of large background noise given by carbon
groups naturally present in HS [34,35,46]. HS also affect the
resistance of MoPrP to biotic degradation, as reported in our
controlled PK digestion experiments. We argue that prions may be
adsorbed by HS in soil rich in OM content and at least partially
hidden by natural proteases, thus persisting in the environment for
years. This observation is in agreement with current studies
proposing that embedding into HS promotes protein preservation
in natural environments. On the other hand, this may reduce HS-
embedded protein activity and bioavailability [30,31].
We have provided a morphological description of MoPrP-HS
insoluble complexes by optical microscopy and AFM. These
techniques have been employed to study the topography and
conformational structures of HS on solid surface [47–49] as well as
protein complexes formed with soil or HS [23,50]. We used mica
as substrate because its surface properties are similar to those of
minerals present in terrestrial environments. Differently from HA
and HA-MoPrP, FA and FA-MoPrP complexes exhibit ordered
structures forming large branches fairly distributed on the surface.
The lower molecular weight of FA and their higher oxygen
content compared to HA –which are rather a complex mixture of
different acids with a variety of functional groups [27]– enable
these acids to arrange in regular structures depending on FA
concentration and on the presence of proteins or other ligands
[48,51–53]. The peculiar structural plasticity of FA was clearly
visible in AFM experiments showing sponge-like structures and
globular assemblies at low MoPrP and FA concentrations,
respectively, while at high MoPrP concentration FA appeared
assembled in fibrillar structures. Although AFM provides only
morphological information, these fibrils are reasonably made only
of FA, as their height is not compatible with current studies on PrP
fibrils dimension [43], and as FA cannot generate ThT-positive
Figure 5. Effectiveness of HS in inhibiting prion replication. ASA showing the kinetics of MoPrP fibrillization in the presence of 1 mg/mL of HS
(A) and the corresponding mean value of the lag phases (in hours) for MoPrP treated with HS (**P,0.01) (B). In (C) Western-blot results showing the
dose-dependent removal of PrPSc from ScGT1 cells. In the upper panel, total PrP expression detected by immunoblotting after the addition of
increasing concentrations of HA and FA (here used as non-PK controls); the lower panel shows PrPSc levels after digestion with PK.
doi:10.1371/journal.pone.0100016.g005
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MoPrP aggregates. Taken together, these findings indicate that
protein encapsulation by HS causes the formation of large
insoluble aggregates, as is the case with HA, or ordered structures
made of FA. Interestingly, FA appear more effective in inducing
MoPrP precipitation and in protecting the protein from PK
digestion, arguing for a stronger molecular interaction with
MoPrP, which results in a different, more efficient encapsulation.
The observed ability of HS to promote MoPrP adsorption raises
the question whether they can interact in a similar way also with
PrPSc. It has been reported that HS may form adducts with
proteins having biochemically different features [29,31,54] and a
recent study has shown a direct interaction between different types
of HA and two PrPSc strains, isolated from hamster-adapted
transmissible mink encephalopathy and from CWD-affected deer
[55]. Our findings, based on ASA and ScGT1 cell assays, support
the hypothesis that HS effectively hinder prion conversion and
infectivity. The observation that HS interact with a-helix folded
MoPrP provides a molecular explanation for their effect in
inhibiting MoPrP fibrillization and in clearing PrPSc from ScGT1.
Therefore, we argue that prions may be strongly retained in
soils with higher HS content, thus reducing the odds of infectivity
among grazing lands. HS-mediated adsorption may promote
prion preservation from biotic and abiotic degradation; on the
other hand, HS might also limit prion bioavailability to animals
exposed to contaminated soils. Previous studies show that prions
bound to a soil rich in OM (e.g. Dodge soil) are less infectious than
PrPSc adsorbed to montmorillonite [20]. As shown by mild
thermal denaturation, FA inhibit the conversion of recPrP to a
PK-resistant PrPSc-like conformation, which is not available for
cell internalization when bound to FA [32]. A recent study has
reported that HA-adsorbed PrPSc strains resulted slightly less
infectious when intracerebrally inoculated in hamsters [55].
Nevertheless, further investigations in living organisms are needed
to verify this hypothesis. Our data provide a platform for ongoing,
rationally designed experiments aimed at elucidating whether
mammalian prions adsorbed into HS are still infectious when
orally transmitted in animal models.
Supporting Information
Figure S1 Adsorption of MoPrP into HS monitored by
CD spectroscopy. Decrease in millidegree (mdeg) absorbance
on the CD spectra of MoPrP after 6 hours of incubation with HA
(A), FA (B) and 240 hours of incubation with HA (C).
(TIF)
Figure S2 Estimated concentration of MoPrP in solution
after HS addition using MoPrP standards. CD spectra of
MoPrP standards (125, 100, 75 and 50 mg/mL) were acquired (A)
and the equation resulting from the linear fitting of the mdeg value
at 208 nm vs. the MoPrP standards was derived (B).
(TIF)
Figure S3 AFM surface morphology of MoPrP in
complex with low HS concentration. AFM surface recon-
struction of a MoPrP solution (60 mg/mL) drop-casted on a freshly
cleaved mica surface (A). In B and C, respectively, surface
characterization of the MoPrP-HA and MoPrP-FA complexes
formed by 60 mg/mL of MoPrP and 5 mg/mL of HA or FA.
Height profiles, marked by red lines on panels, evidenced a flat
layer in A characterized by a height of about 1.460.2 nm,
whereas a more globular morphology appeared in panels B and C.
(TIF)
Figure S4 Fibrillization reactions of MoPrP in the
presence of 1 mg/mL HS without PrPSc addition. No
significant sigmoidal ThT-fluorescence increases were detectable
in the tested conditions.
(TIF)
Figure S5 Viability experiments on ScGT1 cells treated
with FA (upper panel) and HA (lower panel) as evaluated
in the calcein-AM assay.
(TIF)
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